MEND Insider Trading Activity and SEC Form 4 Filings
MEND insider trading summary
No open-market insider purchases or sales of Micrus Endovascular Corp (MEND) have been reported on SEC Form 4 in the past 12 months.
Latest MEND insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 17, 2010 | Carolyn M Bruguera | Vice Pres. & General Counsel | Sell | $125 (7 @ $17.89) |
| Mar 3, 2010 | Hbm Bioventures Cayman Ltd | 10% Owner | Sell | $445K (21,200 @ $20.98) |
| Mar 2, 2010 | Hbm Bioventures Cayman Ltd | 10% Owner | Sell | $977K (46,196 @ $21.15) |
| Feb 24, 2010 | Hbm Bioventures Cayman Ltd | 10% Owner | Sell | $598K (30,000 @ $19.93) |
| Feb 23, 2010 | Hbm Bioventures Cayman Ltd | 10% Owner | Sell | $801K (40,000 @ $20.02) |
| Feb 22, 2010 | Hbm Bioventures Cayman Ltd | 10% Owner | Sell | $1.3M (65,000 @ $20.52) |
| Feb 19, 2010 | Hbm Bioventures Cayman Ltd | 10% Owner | Sell | $42K (1,940 @ $21.68) |
| Feb 17, 2010 | Richard Snyder | VP, Human Resources | Sell | $18K (880 @ $20.66) |
| Feb 11, 2010 | Edward F Ruppel Jr | Vice President | Sell | $129K (6,904 @ $18.75) |
| Feb 11, 2010 | Edward F Ruppel Jr | Vice President | Sell | $34K (1,832 @ $18.77) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.